Skip to content

Orthostatic, Respiratory, Balance-Intervention

Effect of Inspiratory Muscle Training (IMT) on Breathing, Balance, and Blood Pressure Maintenance in Spinal Cord Injury (SCI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04210063
Acronym
ORB-I
Enrollment
18
Registered
2019-12-24
Start date
2019-12-13
Completion date
2020-07-29
Last updated
2020-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Breathing, Diaphragm, Balance, Blood Pressure

Brief summary

The purpose of this study is to help understand how training breathing muscles will impact balance, blood pressure, and quality of life of participants with spinal cord injury.

Interventions

OTHERInspiratory Muscle Training (IMT)

IMT is a breathing training technique customized to participant's breathing capacity. Using a handheld electronic manometer (Pro2Fit from Smithfield), a study personnel will initiate training at 40-60% maximal inspiratory pressure. Adjustments will be customized to where the participant reports a difficulty of training between 4-6 out of 10. Training sessions will be performed about 30 minutes a day for 28 consecutive days.

Sponsors

Foundation for Physical Therapy, Inc.
CollaboratorINDUSTRY
The Craig H. Neilsen Foundation
CollaboratorOTHER
University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Upper/lower/both extremity weakness or paralysis resulting from SCI with ASIA Impairment Scale (AIS) grades A-C who use a wheelchair as primary means of mobility. 2. ≥1 year post-injury 3. Willingness to participate in the study and provide consent.

Exclusion criteria

1. Inability to understand the consent form or consent process 2. Reliance on a mechanical ventilator. 3. Use of Betablockers 4. Inability to travel to The Miami Project for weekly sessions during intervention month 5. Any complication that would limit transfer ability, or compromise supine or sitting tolerance, including but not limited to: * Fracture, dislocation, or malformations affecting supine or sitting tolerance. * Spinal instability. * Pressure ulcers or skin integrity issues on contact surfaces that would prohibit sitting or lying in supine. 6. Individuals who are able to stand independently or with a walker 7. Unresolved deep vein thrombosis (DVT). 8. Hospitalization due to autonomic dysreflexia in the last 3 months. 9. Pregnancy determined by urine testing in sexually active females.

Design outcomes

Primary

MeasureTime frameDescription
IndependenceWeek 12Independence will be measured using the Spinal Cord Independence Measured (SCIM). SCIM has a total score ranging from 0-100 with the higher score indicating increased independence.
Maximal Inspiratory Pressure (MIP)Week 12MIP measured in cm H2O will be assessed using the Pro2 handheld inspiratory measurement and training device connected to a tablet, phone or desktop
Sustained Maximal Inspiratory Pressure (SMIP)Week 12SMIP measured in pressure-time units (PTU) will be assessed using the Pro2 handheld inspiratory measurement and training device connected to a tablet, phone or desktop.
Standard deviation of normal R-R intervals (SDNN)Week 12SDNN, measured in milliseconds, will be derived from signals obtained by a Polar monitor (with elastic chest strap sensor) and analyzed using Kubios Heart Rate Variability (HRV) Analysis Software.
Root Mean Squared of Successive Differences between Normal Heartbeats (rMSSD)Week 12rMSSD, measured in milliseconds, will be derived from signals obtained by a Polar monitor (with elastic chest strap sensor) and analyzed using Kubios Heart Rate Variability (HRV) Analysis Software.
Systolic Blood Pressure (SBP)Week 12Brachial systolic BP, evaluated in mmHg, will be evaluated using the contralateral arm with a Spot Vitals Monitor.
Functional Seated BalanceWeek 12Functional Seated Balance will be measured using the Function in Sitting Test for SCI (FIST-SCI). FIST-SCI consist of 14 different standardized seated balance tasks and scored on a 5-point ordinal scale from 0-4. A higher score indicates increased independence.
Quality of Life (QoL)Week 12QoL will be measured using the Quality of Life Index, SCI version (QOLI-SCI). QOLI-SCI is a set of two 37-items questionnaire with total scores ranging from 74 to 444 with the higher score indicating increased quality of life.
Percent Compliance of Training Sessions4 weeksFeasibility of the IMT protocol will be reported as the percentage of completed daily sessions out of the 28 total session days.
Percent Compliance of Training Minutes4 weeksFeasibility of the IMT protocol will also be reported as the percentage of completed total time out of the 840 minutes total expected session minutes(30 minutes daily for 28 days).

Secondary

MeasureTime frameDescription
Forced Vital CapacityWeek 12FVC, evaluated in liters, will be measured using a handheld digital spirometer device.
Forced Expiratory Volume in one Second (FEV1)Week 12FEV1, evaluated in liters, will be measured using a handheld digital spirometer device.
Peak Expiratory Flow (PEF)Week 12PEF, evaluated in liters/minute, will be measured using a handheld digital spirometer device.
Maximal Expiratory Pressure (MEP)Week 12MEP, evaluated in cm H2O, will be measured using a handheld digital spirometer device.
Heart Rate Variability (HRV) FrequencyWeek 12Low Frequency (LF) and High Frequency (HF) Power, reported in percentage, will be derived from signals obtained by a Polar monitor (with elastic chest strap sensor) and analyzed using Kubios Heart Rate Variability (HRV) Analysis Software.
Diastolic Blood Pressure (DBP)Week 12Brachial diastolic BP, evaluated in mmHg, will be evaluated using the contralateral arm with a Spot Vitals Monitor.
Inspiratory Duration (ID)Week 12ID measured in seconds will be assessed using the Pro2 handheld inspiratory measurement and training device connected to a tablet, phone or desktop.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026